CNS Tumors Classification and Features

Understanding the classification of central nervous system (CNS) tumors is fundamental for medical diagnosis, treatment planning, and board exams. These tumors are defined not just by their malignancy but by their precise anatomical location, cell of origin, and distinct histological patterns. For you as a student, mastering these features provides a framework for predicting clinical presentation, imaging findings, and patient prognosis.

Principles of CNS Tumor Classification

CNS tumors are primarily classified by the cell of origin from which they arise. This is a critical first step because a tumor's behavior—its growth rate, invasiveness, and response to treatment—is intrinsically linked to its cellular lineage. Neuroepithelial cells give rise to tumors like gliomas, meningeal cells to meningiomas, and Schwann cells to schwannomas.

The second key axis is anatomical location. A tumor's position within the brain or spinal cord dictates its clinical symptoms due to compression or infiltration of specific neural structures. For instance, a mass in the posterior fossa will present with very different signs than one in the frontal lobe. Finally, histologic characteristics—what the tumor looks like under a microscope—determine its grade and final diagnosis. Features like cellular atypia, mitotic activity, and necrosis are used in grading systems, most commonly the World Health Organization (WHO) grading scheme from I (most benign) to IV (most malignant).

Glioblastoma Multiforme (GBM)

Glioblastoma multiforme (GBM) represents a WHO grade IV astrocytoma and is the most common primary malignant brain tumor in adults. Its cell of origin is the astrocyte, a type of glial cell. Histologically, GBM is defined by two hallmark features: pseudopalisading necrosis (necrotic areas surrounded by densely packed, palisading tumor cells) and microvascular proliferation (the abnormal, rapid growth of blood vessels within the tumor).

A classic and highly testable imaging finding is its tendency to infiltrate across white matter tracts. When a GBM in one cerebral hemisphere spreads via the corpus callosum (the major commissural tract connecting the hemispheres) to the opposite side, it forms a distinctive "butterfly glioma" on MRI. Clinically, patients present with rapidly progressive neurological deficits, headaches, and signs of increased intracranial pressure. Despite aggressive treatment with surgery, radiation, and chemotherapy, the prognosis remains poor, with a median survival of approximately 15 months.

MCAT/Board Focus: The correlation between histology (pseudopalisading necrosis) and imaging (butterfly glioma) is a classic association. Remember that "primary" GBM arises de novo, while "secondary" GBM progresses from a lower-grade astrocytoma.

Meningioma

In contrast to GBM, meningioma is typically a benign (WHO grade I), slow-growing tumor and is the most common benign brain tumor overall. It arises from arachnoid cap cells, specifically from the arachnoid villi. These tumors are extra-axial, meaning they grow outside the brain parenchyma itself, often adhering to the dura mater.

Common locations include along the falx cerebri, cerebral convexities, and sphenoid wing. Histologically, meningiomas exhibit a whorled pattern of cells, and some may form psammoma bodies (concentrically laminated calcifications). Patients are often asymptomatic, with the tumor discovered incidentally. When symptoms occur, they are due to mass effect and can include focal seizures, progressive weakness, or personality changes depending on location. Treatment is usually surgical resection, and the prognosis is excellent for grade I tumors.

MCAT/Board Focus: The link between cell of origin (arachnoid) and typical extra-axial location is key. Meningiomas are a prime example of a benign tumor that can still cause significant morbidity due to mass effect in the confined cranial space.

Vestibular Schwannoma

A schwannoma is a benign tumor arising from Schwann cells, which produce the myelin sheath for peripheral nerves. The most clinically significant intracranial schwannoma is the vestibular schwannoma (formerly called acoustic neuroma), which originates from the vestibulocochlear nerve (CN VIII). It is most commonly located at the cerebellopontine angle (CPA), the junction between the pons, cerebellum, and medulla.

The classic and often first clinical symptom is unilateral, progressive sensorineural hearing loss and tinnitus due to compression of the cochlear nerve. As it grows, it can compress the trigeminal nerve (CN V), causing facial numbness, and the facial nerve (CN VII), leading to weakness. Large tumors can cause brainstem compression and hydrocephalus. Histology shows alternating areas of dense cellularity (Antoni A areas) and loose, myxoid tissue (Antoni B areas). Treatment options include observation, stereotactic radiosurgery, or microsurgical resection.

MCAT/Board Focus: The CPA is a vital anatomical "crossroads." The presentation of unilateral hearing loss should immediately raise suspicion for a vestibular schwannoma. Remember its association with Neurofibromatosis type 2 (bilateral schwannomas).

Medulloblastoma

Medulloblastoma is a highly malignant (WHO grade IV) embryonal tumor and is the most common malignant brain tumor in children. It arises in the posterior fossa, specifically from the cerebellum or fourth ventricle. Its cell of origin is believed to be primitive neuroectodermal cells in the cerebellar granular layer.

Histologically, it is a "small blue round cell tumor" with densely packed cells exhibiting high mitotic activity. Due to its location, it often causes obstructive hydrocephalus by blocking the fourth ventricle, presenting with symptoms of increased intracranial pressure like morning headache, nausea, vomiting, and ataxia. A critical feature is its tendency to spread via the cerebrospinal fluid (CSF), requiring staging of the entire neuraxis. Treatment involves maximal surgical resection, craniospinal radiation, and chemotherapy.

MCAT/Board Focus: The triad of "child + posterior fossa tumor + hydrocephalus" is classic for medulloblastoma. Its propensity for CSF "drop metastases" to the spinal cord is a crucial differential and management point compared to other pediatric posterior fossa tumors like pilocytic astrocytoma.

Common Pitfalls

1. Equating "Benign" with "Harmless": A common mistake is to assume a benign tumor like a meningioma is inconsequential. In the rigid confines of the skull, even a slow-growing, non-invasive tumor can cause severe neurological deficits or life-threatening increased intracranial pressure due to mass effect.
2. Confusing Location and Origin: It is easy to conflate a tumor's location with its tissue origin. For example, a cerebellopontine angle mass is often a schwannoma, but it could also be a meningioma. You must use the location as a clue, but the definitive diagnosis comes from histology and cell of origin (Schwann cell vs. arachnoid cell).
3. Overgeneralizing "Most Common" Facts: Remember that epidemiology shifts with age. Glioblastoma is the most common primary malignant tumor in adults, while medulloblastoma holds that title in children. Meningioma is the most common benign tumor overall. Applying the wrong demographic to the fact is a frequent exam trap.
4. Misidentifying the "Butterfly" Lesion: While a butterfly pattern across the corpus callosum is classic for glioblastoma, it is not pathognomonic. Other entities, like CNS lymphoma or demyelinating disease, can have a similar appearance. Always integrate the pattern with the patient's age and clinical history.

Summary

• CNS tumors are classified by cell of origin, anatomical location, and histologic characteristics, which together determine their behavior, presentation, and prognosis.
• Glioblastoma multiforme (GBM) is a WHO grade IV astrocytoma, the most common primary malignant brain tumor in adults, characterized histologically by pseudopalisading necrosis and radiologically by a "butterfly glioma" when it crosses the corpus callosum.
• Meningioma, arising from arachnoid cap cells, is the most common benign brain tumor, is typically extra-axial, and causes symptoms through gradual mass effect.
• Vestibular schwannoma, a benign tumor of Schwann cells at the cerebellopontine angle, classically presents with unilateral sensorineural hearing loss and tinnitus.
• Medulloblastoma is a malignant embryonal tumor of the posterior fossa and is the most common malignant brain tumor in children; it frequently causes obstructive hydrocephalus and has a high risk of spreading via the cerebrospinal fluid.